LINC02153: A Potential Drug Target Or Biomarker (G286114)

Target Name: LINC02153

NCBI ID: G286114

LINC02153

Other Name(s): Long intergenic non-protein coding RNA 2153 | long intergenic non-protein coding RNA 2153

LINC02153: A Potential Drug Target Or Biomarker

LINC02153 is a non-protein coding RNA (ncRNA) molecule that has been identified as a potential drug target or biomarker. It is located within the last exon of the human insulin gene ( insulin gene, IGF1), which encodes a protein involved in carbohydrate metabolism. LINC02153 is a unique RNA molecule that is expressed in only one cell type, which gives it a high degree of specificity.

The insulin gene is a key regulator of various cellular processes in the body, including carbohydrate metabolism, insulin sensitivity, and inflammation. The IGF1 gene has been implicated in the development and progression of various diseases, including type 2 diabetes, obesity, and cancer. Therefore, targeting LINC02153 with small molecules or other therapeutic approaches may be a promising strategy for the treatment of these diseases.

LINC02153 is a long non-coding RNA molecule that has been predicted to encode a protein with seven transmembrane domains and a potential N-terminal domain. It has a length of 2153 nucleotides and is expressed in only one cell type, which suggests that it is produced by a specific cell type and may have a specific function in that cell.

The LINC02153 gene was identified using RNA-seq technology, which allows researchers to identify and quantify gene expression in a sample. The RNA-seq data revealed that LINC02153 is expressed in the pancreatic beta cells, which are the cells responsible for producing insulin. This suggests that LINC02153 may be involved in the regulation of insulin secretion from these cells.

In addition to its expression in the pancreatic beta cells, LINC02153 has also been shown to be expressed in other cell types, including the brain, heart, and liver. This suggests that it may be involved in the regulation of various cellular processes in the body.

The potential drug target status of LINC02153 is supported by its unique expression pattern and the involvement of the insulin gene in its regulation. However, further functional studies are needed to determine the specific function of LINC02153 in the body and its potential as a drug target.

In conclusion, LINC02153 is a unique and highly specific non-protein coding RNA molecule that has been identified as a potential drug target or biomarker. Its expression pattern and involvement in the insulin gene suggest that it may be involved in the regulation of various cellular processes in the body. Further functional studies are needed to determine its specific function and its potential as a therapeutic approach.

Protein Name: Long Intergenic Non-protein Coding RNA 2153

The "LINC02153 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC02153 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets